ReviewKidney diseases (Basel, Switzerland)2022

Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease.

Henry H L Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.